177
Views
20
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Continuation and compliance of contraceptive use

Pages 178-183 | Published online: 06 Jul 2009

REFERENCES

  • Trussell J, Kowal D. The essentials of contraception. Efficacy, safety, and personal consideration. In Hatcher RA, Trussell J, Stewart F, et al., eds. Contraceptive Tech- nology, 17th edn. New York: Ardent Media, Inc., 1998:211–47
  • Newton J. Contraceptives: regional perspectives, issues, and unmet needs – the European perspective. Int J Gynecol Obstet 1998; 62(Suppl 1):S25–30
  • Rosenberg M, Waugh M. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 1999;180:S276–9
  • Trussell J, Kost K. Contraceptive failure in the United States: a critical review of the literature. Stud Fam Plann 1987;18:237–83
  • Vaughan B, Trussell J, Menken J, et al. Contraceptive efficacy among married women aged 15–44 years. In Vital and Health Statistics, 1980, Series 23, No. 5. Washington, DC: National Center for Health Statistics, 1981: DHHS Pub.No.PHS 80
  • Grady WR, Hayward MD, Florey FA. Contraceptive discontinuation among married women in the United States. Stud Fam Plann 1988;19:227–35
  • Grady WR, Hirsch MB, Keen N, Vaughan B. Contra- ceptive failure and continuation among married women in the United States, 1970–75. Stud Fam Plann 1983;14:9–19
  • Trussell J. Contraceptive efficacy. In Hatcher RA, Trussell J, Stewart F, et al., eds. Contraceptive Technology. 17th edn. New York: Ardent Media, Inc., 1998:779–99
  • La Valleur J, Wysocki S. Selection of oral contraceptives or hormone replacement therapy: patient communica- tion and counseling issues. Am J Obstet Gynecol 2001; 185:S57–64
  • Pinter B. Continuation of contraceptive use in Slovenia – life-table analysis. In 8th Congress of European Associa- tion of Gynaecologists and Obstetricians. Book of Abstracts. Ljubljana: University Department of Obstetrics and Gynecology, 1993:RP3–6
  • Potter RG Jr. Additional measures of use-effectiveness of contraception. Milbank Mem Fund Q 1963;41:400–18
  • Tietze C. The use-effectiveness of contraceptive methods. In Kiser CV, ed. Research in Family Planning. Princeton: Princeton University Press, 1962:358–61
  • Potter RG Jr. Application of life-table techniques to measurement of contraceptive effectiveness. Demo- graphy 1966;3:297–304
  • Farley TMM. Life-table methods for contraceptive research. Stat Med 1986;5:475–89
  • Pinter B. Continuation of contraceptive use in Slovenia – life-table analysis. Eur J Obstet Gynecol Reprod Biol 1994; 55:54
  • Dardano KL, Burkman RT. Contraceptive compli- ance. Obstet Gynecol Clin North Am 2000;27:933–41
  • Cramer JA. Compliance with contraceptives and other treatments. Obstet Gynecol 1996; 88(Suppl 3):4S–12S
  • Branden PS. Contraceptive choice and patient compli- ance. The health care provider’s challenge. J Nurse Midwifery 1998;43:471–82
  • Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995;51:283–8
  • Zheng SR, Theng HM, Qian SZ, et al. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China. Eur J Contracept Reprod Health Care 1999;4:85–93
  • Croxatto HB. Clinical profile of implantation: a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000; 5(Suppl 2): 21–8
  • Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002;65:29–37
  • Garceau RJ, Wajszcuk CJ, Kaunitz AM. Bleeding patterns of women using Lunelle monthly contracep- tive injections (medroxyprogesterone acetate and estra- diol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. Contraception 2000;62:289–95
  • Kaunitz AM. Lunelle monthly injectable contraceptive. An effective, safe and convenient new birth control option. Arch Gynecol Obstet 2001;265:119–23
  • Mulders TM, Dieben TO. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril 2001;75:865–70
  • Bjarnadottir RI, Tuppurainene M, Killick SR. Com- parison of cycle control with combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 2002;186:389–95
  • Zieman M, Guillebaud J, Weisberg E, et al. Contracep- tive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002;77(2 Suppl 2): S13–18
  • Archer DF, Bigrigg A, Smallwood GH, et al. Assess- ment of compliance with weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril 2002;77(2 Suppl 2): S27–31
  • Grow DR, Ahmed S. New contraceptive methods. Obstet Gynecol Clin North Am 2000;27:901–16
  • Aubeny E, Colau JC, Nandeuil A. Local spermicidal contraception: a comparative study of the acceptability and safety of a new pharmaceutical formulation of benzalkonium chloride, the vaginal capsule, with a reference formulation, the pessary. Eur J Contracept Reprod Health Care 2000;5:61–7
  • Creatsas G, Guerrero E, Guilbert E, et al. A multi- national evaluation of the efficacy, safety and accept- ability of the Protectaid contraceptive sponge. Eur J Contracept Reprod Health Care 2001;6:172–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.